Department of Medicine, University of Padova, Via Giustiniani 2, Padova, 35128, Italy.
Chronobiology Section, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
Neurochem Res. 2024 Jun;49(6):1529-1540. doi: 10.1007/s11064-023-04034-3. Epub 2023 Oct 4.
It is known that patients with covert hepatic encephalopathy (CHE) exhibit working memory abnormalities, but to date there is no study comparing patients with cirrhosis with/without CHE and controls with both electrophysiological and hemodynamic data collected at the same time.Here we collected behavioral [accuracy and reaction times (RTs), electrophysiological (evoked potentials) and hemodynamic (oxygenated and deoxygenated haemoglobin) correlates of an n-back task [formed by a control (0-back) condition, a low (1-back) and a high (2-back) working memory load conditions] in patients with cirrhosis with/without CHE: (1) at baseline (n = 21, males = 15, 58±8 yrs), and by comparison with controls (n = 21, males = 15, 57±11 yrs) and (2) after a 3-month course of rifaximin (n = 18, males = 12, 61±11 yrs), and by comparison to baseline.All patients showed slower RTs (p < 0.0001) and lower P2 amplitude compared with controls (p = 0.018); moreover, patients with CHE showed reduced accuracy (p < 0.0001) compared with controls, and patients without CHE showed higher oxygenated haemoglobin in the central dorsolateral prefrontal cortex in the 2-back compared with patients with CHE. Post-rifaximin, oxygenated haemoglobin increased in the central frontopolar cortex. In addition, in patients without CHE the RTs of the 2-back became comparable to those of the 0-back and P3 showed higher amplitude.In conclusion, the presence of cirrhosis seemed to have more effects than CHE on working memory at baseline. A course of treatment with rifaximin was more beneficial to patients without CHE, who probably had more room for improvement in this complex task.
已知隐匿性肝性脑病(CHE)患者表现出工作记忆异常,但迄今为止,尚无研究比较同时采集电生理和血流动力学数据的肝硬化伴/不伴 CHE 患者和对照组。在这里,我们收集了行为[准确性和反应时间(RT)、电生理(诱发电位)和血流动力学(含氧和去氧血红蛋白)与 n-back 任务[由控制(0-back)条件、低(1-back)和高(2-back)工作记忆负荷条件]相关的指标,在肝硬化伴/不伴 CHE 的患者中:(1)在基线时(n=21,男性=15,58±8 岁),并与对照组(n=21,男性=15,57±11 岁)进行比较,(2)在接受利福昔明治疗 3 个月后(n=18,男性=12,61±11 岁),并与基线相比。所有患者的 RT 均较慢(p<0.0001),与对照组相比 P2 振幅较低(p=0.018);此外,CHE 患者的准确性较低(p<0.0001),与 CHE 患者相比,无 CHE 患者在 2-back 时中央背外侧前额叶皮质的含氧血红蛋白升高。利福昔明治疗后,中央额极皮质的含氧血红蛋白增加。此外,在无 CHE 的患者中,2-back 的 RT 变得与 0-back 相当,P3 的振幅更高。总之,在基线时,肝硬化的存在似乎比对 CHE 的影响更大。利福昔明治疗对无 CHE 的患者更有益,这些患者在这项复杂任务中可能有更大的改善空间。